Rising medical and prescription drug plan costs are skyrocketing, thanks in part to a high-risk group well-known as high-cost claimants. Despite making up just one percent of plan membership, their expenses account for nearly half of the total cost. Lately, the prevalence and severity of high-cost claims have reached alarming levels, leaving employers grappling with the financial burden. This surge is fueled by exorbitantly priced injectable drugs, increasingly complex treatments, and a growing population with multiple chronic conditions.
In this webcast, hear the latest trends in high-cost claimants, cell and gene therapy, and how predictive modeling can empower employers to take control of their spend through proactive mitigation and budgeting.
Meet the Presenters:
Marnie Bute is a Managing Director in the Accident, Health, and Reinsurance Solutions unit of Aon. In her role, she is responsible for developing innovative and cost-effective reinsurance solutions for clients to support their long-term risk, capital, and growth strategies. Bute is also responsible for developing sales and marketing strategies to cultivate new business growth focused on Managed Care and Medical Reinsurance. Additionally, she leads efforts within Aon’s Healthcare Vertical to address the clinical challenges, coverages and financing, in complex conditions and related treatments such as transplantation, gene and cell therapies.
Meghan Rausch is a Vice President and health actuary in Aon’s Health Solutions Commercial Analytics practice, with a focus on innovation, new solution development, and vendor partnerships. She has over 10 years of experience working as an actuary supporting large employers’ health and benefits strategy. Rausch leads Aon’s Health Risk Navigator solution, which helps employers apply predictive modeling to understand their future high-cost claimant exposure to proactively mitigate and manage costs. She is a Fellow of the Society of Actuaries and a Member of the American Academy of Actuaries.
Tiffiny Hagberg is a Vice President in Aon’s Health & Benefits practice. She leads consulting relationships with large, complex organizations, helping employers develop and implement U.S. health and benefits strategies to support their overall business objectives. Hagberg assists with strategy development, plan design, vendor management, and compliance. She also supports her clients with merger, acquisition and divestiture issues related to health and welfare benefits. Hagberg joined Aon in 2021 and has over 25 years of experience in health and benefits, including 22 years working in the pharmacy benefit management industry.
Check out the Health Risk Navigator and additional resources.
Health Risk Navigator
A Surge in Gene and Cell Therapies Raises Financing Questions
Integrating Workforce Data to Uncover Hidden Insights
On Aon’s View of Technology Impacting the Future of Health and Benefits